KELLY OSSMAN: Open Payments
NPI 1073268694 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,234 in 53 payments from 17 companies in 2025. Trend: 2023 $1,075 · 2024 $1,491 · 2025 $1,234
Food & beverage: $1,234
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 7 | $275 |
| Lilly USA, LLC | 10 | $217 |
| Teva Pharmaceuticals USA, Inc. | 10 | $157 |
| ABBVIE INC. | 6 | $147 |
| UCB, Inc. | 3 | $75 |
| PFIZER INC. | 3 | $61 |
| Alexion Pharmaceuticals, Inc. | 2 | $55 |
| JAZZ PHARMACEUTICALS INC. | 2 | $43 |
| SK Life Science, Inc. | 2 | $38 |
| CATALYST PHARMACEUTICALS, INC. | 1 | $31 |
Products named: Leqembi, KISUNLA, AUSTEDO XR, QULIPTA, NURTEC ODT, ULTOMIRIS, BOTOX, EPIDIOLEX.
Industry payments across NY — which companies pay providers there.
